Come up with a name for your new list and we'll add to it:
CureVac raised a round of funding on October 17, 2017. Investors include
Eli Lilly & Co..
CureVac, a German clinical stage biopharmaceutical company founded in 2000, is pioneering the field of mRNA-based technology platforms for medical purposes, in which unmodified mRNA is specifically op…